(Q34765290)

4 August 2017

1 reference

title

Erythroleukemia: a need for a new definition (English)

1 reference

4 August 2017

main subject

acute erythroid leukemia

1 reference

Park S

1

1 reference

4 August 2017

Picard F

series ordinal

2

1 reference

4 August 2017

Dreyfus F

series ordinal

3

1 reference

4 August 2017

publication date

1 August 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

16

1 reference

4 August 2017

issue

8

1 reference

4 August 2017

page(s)

1399-1401

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402549

4 August 2017

exact match

0 references

cites work

Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402549

7 January 2021

The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402549

7 January 2021

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402549

7 January 2021

Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402549

7 January 2021

Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402549

7 January 2021

The acute erythroleukemias.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402549

7 January 2021

Effects of multidrug resistance gene expression in acute erythroleukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402549

7 January 2021

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402549

7 January 2021

Erythroleukemia: a comparison between the previous FAB approach and the WHO classification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402549

7 January 2021

Minimally differentiated erythroleukaemia (AML M6 Variant'): a rare subset of AML distinct from AML M6

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402549

7 January 2021

Erythroleukemia: a review of 15 cases meeting 1985 FAB criteria and survey of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402549

7 January 2021

Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402549

7 January 2021

Morphologic, immunologic and cytogenetic studies in erythroleukaemia: evidence for multilineage involvement and identification of two distinct cytogenetic-clinicopathological types

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402549

7 January 2021

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402549

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402549

1 reference

Dimensions Publication ID

4 August 2017

1032005173

0 references

Fatcat ID

release_5ovqvng42jaypekhi43lnc6pdu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5ovqvng42jaypekhi43lnc6pdu

24 November 2022

mapped directly with Wikidata item

1 reference